FibroGen Balance Sheet Analysis

Assets, liabilities, and stockholders equity in billions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for FibroGen, Inc. (FGEN) - Annual data in billions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Current Assets
Cash and Cash Equivalents0.050.200.420.170.680.530.62
Short-Term Investments0.000.120.270.230.010.000.00
Cash & Short-Term Investments0.050.200.420.410.690.530.62
Accounts Receivable0.000.010.020.030.040.030.06
Inventory0.000.020.040.030.020.010.00
Other Current Assets0.000.070.000.010.010.000.00
Total Current Assets0.200.330.490.470.760.700.69
Non-Current Assets
Property, Plant & Equipment (Net)0.000.070.100.120.070.040.13
Long-Term Investments0.000.010.010.170.000.000.00
Other Non-Current Assets0.020.020.010.010.000.050.01
Total Non-Current Assets0.020.090.120.300.070.150.19
Total Assets0.210.420.610.770.830.860.88
Current Liabilities
Accounts Payable0.010.150.250.030.020.090.07
Accrued Liabilities0.030.100.200.120.090.000.00
Deferred Revenue0.030.010.010.020.020.000.00
Other Current Liabilities0.070.040.020.050.010.040.01
Total Current Liabilities0.130.220.270.230.160.100.09
Non-Current Liabilities
Long-Term Debt0.070.140.080.020.020.040.10
Other Non-Current Liabilities0.080.070.010.030.040.070.03
Total Non-Current Liabilities0.260.370.290.320.220.220.26
Total Liabilities0.400.590.610.540.390.320.35
Stockholders' Equity
Common Stock0.000.000.000.000.000.000.00
Retained Earnings-1.89-1.85-1.56-1.26-0.97-0.78-0.72
Accumulated Other Comprehensive Income-0.01-0.01-0.010.000.000.000.00
Additional Paid-in Capital1.671.641.541.481.401.301.23
Minority Interest0.040.040.020.020.020.020.02
Shares Outstanding0.000.000.000.000.000.000.00
Total Stockholders' Equity-0.23-0.180.000.230.440.540.53
Total Liabilities & Equity0.210.420.610.770.830.860.88